
Wednesday, June 01, 2005 1:54:48 PM
I copied this of the DNAP site.....
The NEW and IMPROVED site....
it's COSMIC in every sense of the word....LOL
STATNOME is a genetic test that measures a patient’s likelihood to develop myalgia as an adverse response to the commonly prescribed Statins Lipitor1 and Zocor2.Myalgia is a Statin side-effect condition characterized by muscle pain, and is a first symptom of the potentially fatal muscle-wasting disease rhabdomyolysis. Though only 1 in every 10,000 patients experiences rhabdomyolysis, about 1% of Lipitor1and Zocor2 users experience it’s precursor myalgia. Bayers Statin Baycol3 was recently withdrawn from the market due to an unacceptable fatality rate due to rhabdomyolysis.
1-Lipitor is a registered trademark of
2-Zocor is a registered trademark of
3-Baycol is a registered trademark of Bayer Corporation.
It is JMHO but why is Bayers mentioned ....
and not the others????....
Was Lipitor1 and Zocor2 removed from the market???....
To me it just seems very strange to name one and not the others....
maybe they had Bayers permission...
If I was Bayers and had the ability to put Baycol3 back on the shelves, I think i would....
Like I said JMHO---GEO
ConnectM Announces Q1 2025 Preliminary Revenue Guidance of $11.3M, Representing a 100% Year-Over-Year Surge • CNTM • Feb 21, 2025 7:17 AM
Consumer Automotive Finance Inc. (CAFI) Completes Final Steps with FINRA, Expects Name and Ticker Change to Fifty 1 Labs, Inc. (FITY) Within 30 Days • CAFI • Feb 20, 2025 9:00 AM
UAV Corp Unveils AIG's Arrival and Cutting-Edge 3D Printing Technology, Paving the Way for Full-Scale T-Wing UAS Production and the Future of Aerospace and Defense Manufacturing • UMAV • Feb 20, 2025 8:30 AM
North Bay Resources Announces Production of 8.5 Ounces Per Ton Gold Concentrate, Bishop Gold Mill, California • NBRI • Feb 19, 2025 8:59 AM
YCRM ReachOut Technology Returns to Trading: CEO Rick Jordan Lays Out Blockchain CyberSecurity Strategy and Industry-First AI MSP Partnership In Shareholder Letter • YCRM • Feb 18, 2025 11:20 AM
VAYK Confirms No Dilution Following Recent Acquisition and 11 Million Insider Purchase • VAYK • Feb 18, 2025 9:30 AM